Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist

European Urology

Volumn 65, Issue 3, 2014, Pages 565-573

  Albertsen, Peter C ^a   Klotz, Laurence ^b   Tombal, Bertrand ^c   Grady, James ^a   Olesen, Tine K ^d   Nilsson, Jan ^e  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d Ferring Pharmaceuticals AS   (Denmark)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Androgen deprivation therapy; GnRH antagonist; Prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; GNRH ANTAGONIST; PROSTATE CANCER;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS, PHASE III AS TOPIC; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84895058731     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.10.032     Document Type: Article

References (30)

1. A.V. D'Amico, J.W. Denham, and J. Crook et al. Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions J Clin Oncol 25 2007 2420 2425 (Pubitemid 46999213)
2. N.L. Keeting, A.J. O'Malley, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 2006 4448 4456 (Pubitemid 46630983)
3. L. Bourke, P. Kirkbride, R. Hooper, A.J. Rosario, T.J. Chico, and D.J. Rosario Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness? Br J Cancer 108 2013 9 13
4. V. Conteduca, G. DiLorenzo, A. Tartarone, and M. Aieta The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: an unresolved controversy Crit Rev Oncol Hematol 86 2013 42 51
5. A.V. D'Amico, M.H. Chen, and A.A. Renshaw et al. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289 295 (Pubitemid 351159365)
6. A.N. Nanda, M.H. Chen, M.H. Braccioforte, B.J. Moran, and A.V. D'Amico Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction JAMA 302 2009 866 873
7. C.S. Saigal, J.L. Gore, and T.L. Krupski et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer Cancer 110 2007 1493 1500 (Pubitemid 47463063)
8. G.N. Levine, A.V. D'Amico, and P. Berger et al. Androgen deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and the American Urological Association: endorsed by the American Society of Radiation Oncology Circulation 121 2010 833 840
9. S. Ginzburg, and P.C. Albertsen The timing and extent of androgen deprivation therapy for prostate cancer: weighing the clinical evidence Endocrinol Metab Clin N Am 40 2011 615 623
10. V. Pagliarulo, S. Bracarda, and M.A. Eisenberger et al. Contemporary role of androgen deprivation therapy for prostate cancer Eur Urol 61 2012 11 25
11. S.G. Mohile, K. Mustian, K. Bylow, W. Hall, and W. Dale Management of complications of androgen deprivation therapy in older man Crit Rev Oncol Hematol 70 2009 235 255
12. A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, and G.A. Wittert Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis J Clin Endocrinol Metab 96 2011 3007 3019
13. G. Corona, G. Rastrelli, and M. Monami et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study Eur J Endocrinol 165 2011 687 701
14. D.M. Kelly, and T.H. Jones Testosterone: a metabolic hormone in health and disease J Endocrinol 217 2013 R25 R45
15. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
16. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
17. E. Falk, P.K. Shah, and V. Fuster Coronary plaque disruption Circulation 92 1995 657 671
18. P. Libby, and P. Theroux Pathophysiology of coronary artery disease Circulation 111 2005 3481 3488 (Pubitemid 40923403)
19. M. Naghavi, P. Libby, and E. Falk et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation 108 2003 1664 1672 (Pubitemid 37243650)
20. E. Falk Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes Am J Cardiol 63 1989 114E-20E
21. F.D. Kolodgie, R. Virmani, and A.P. Burke et al. Pathologic assessment of the vulnerable human coronary plaque Heart 90 2004 1385 1391 (Pubitemid 39626306)
22. A.C. Van der Wal, A.E. Becker, C.M. van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44 (Pubitemid 24026469)
23. J. Frostegard, A.K. Ulfgren, and P. Nyberg et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 145 1999 33 43 (Pubitemid 29292698)
24. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat Immunol 12 2011 204 212
25. A.H. Lichtman, C.J. Binder, S. Tsimikas, and J.L. Witztum Adaptive immunity in atherogenesis: new insights and therapeutic approaches J Clin Invest 123 2013 27 36
26. H.F. Chen, E.B. Jeung, M. Stephenson, and P.C. Leung Human peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro J Clin Endocrinol Metab 84 1999 743 750 (Pubitemid 29075715)
27. F. Tanriverdi, D. Gonzalez-Martinez, Y. Hu, F. Kelestimur, and P.M. Bouloux GnRH-I and GnRH-II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin-2 receptor gamma-chain mrna expression in healthy males Clin Exp Immunol 142 2005 103 110 (Pubitemid 41361011)
28. V.D. Dixit, H. Yang, V. Udhayakumar, and R. Sridaran Gonadotropin- releasing hormone alters the t helper cytokine balance in the pregnant rat Biol Reprod 68 2003 2215 2221 (Pubitemid 36687014)
29. A. Radu, C. Pichon, and P. Camparo et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels N Eng J Med 363 2010 1621 1630
30. S. Costanzo, A. Di Castelnuovo, M.B. Donati, L. Iacoviello, and G. de Gaetano Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease Circulation 121 2010 1951 1959